revelex semaglutide GLP-1s Achieve Weight Loss, Anti-Aging &
Description
Available online: Accessed 24 Jan 2025 Rizvi AA, Rizzo M (2022) The emerging role of dual GLP-1 and GIP receptor agonists in glycemic management and cardiovascular risk reduction
Semaglutide is a weight loss tool, not an arthritis medication
PMID: 41802231
Marc Adajar (in the image above and co-founder of XSculpt) was always known as the fat kid when growing up
That is why retatrutide keeps getting described as the investigational drug most likely to reshape the obesity market once it reaches a decision point
Other recognized adverse effects include injection site reactions, increased heart rate, pancreatitis, and gallbladder disease
